PXK Antibody (N-term) Blocking Peptide
€363.00
In stock
SKU
AC-BP7017a
Background:
PXK is widely expressed in all tissues examined except in heart. It binds to and modulates brain Na,K-ATPase subunits ATP1B1 and ATP1B3 and may thereby participate in the regulation of electrical excitability and synaptic transmission. However, the protein kinase domain is predicted to be catalytically inactive.
Other Names:
PX domain-containing protein kinase-like protein, Modulator of Na,K-ATPase, MONaKA, PXK (HGNC:23326)
Target/Specificity:
The synthetic peptide sequence used to generate the antibody AP7017a was selected from the N-term region of human PXK. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.
Gene Name: PXK (HGNC:23326)
Gene ID: 54899
Primary Accession: Q7Z7A4
Other Accession: Q32NE9
Format: Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.
PXK is widely expressed in all tissues examined except in heart. It binds to and modulates brain Na,K-ATPase subunits ATP1B1 and ATP1B3 and may thereby participate in the regulation of electrical excitability and synaptic transmission. However, the protein kinase domain is predicted to be catalytically inactive.
Other Names:
PX domain-containing protein kinase-like protein, Modulator of Na,K-ATPase, MONaKA, PXK (HGNC:23326)
Target/Specificity:
The synthetic peptide sequence used to generate the antibody AP7017a was selected from the N-term region of human PXK. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.
Gene Name: PXK (HGNC:23326)
Gene ID: 54899
Primary Accession: Q7Z7A4
Other Accession: Q32NE9
Format: Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.
| Is Featured? | No |
|---|
Write Your Own Review